Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Marksans Pharma Ltd. is an Indian pharmaceutical company engaged in the research, manufacturing and marketing of finished dosage pharmaceutical formulations. The company employs the latest technology, automated manufacturing and packing operations and best practices, ensuring the highest quality of healthcare.
Marksans Pharma's manufacturing and R&D facility is located in Goa, India and in Southport, the UK for manufacturing non-sterile liquids, ointments and powder products.
The company has a footprint in the USA, Europe, South East Asia, Africa, Russia & CIS, Latin America and Australia.
| Issue Period | July 15, 2022 - January 14, 2023 |
| Security Name | Marksans Pharma Ltd |
| Issue Type | Open Market Through Stock Exchange |
| Issue Size (Amount) | ₹60.00 Crores |
| Buyback Price | ₹60 per share |
| Face Value | ₹1 per share |
| Listing At | BSE, NSE |
| Particulars | For the year/period ended (Rs. in Lakhs) | ||
|---|---|---|---|
| 31-Mar-22 | 31-Mar-21 | 31-Mar-20 | |
| Total Income | 1,53,269.20 | 1,38,287.61 | 1,13,453.67 |
| Profit After Tax | 18,681.40 | 23,853.88 | 12,075.27 |
| Net Worth | 1,04,216.44 | 86,972.58 | 61,990.88 |
| Reserves and Surplus | 99,623.30 | 82,379.44 | 57,397.74 |
| Month | High Price | Low Price | Average Price |
|---|---|---|---|
| Jun-2022 | 48.10 | 38.70 | 44.28 |
| May-2022 | 53.45 | 44.50 | 48.20 |
| Apr-2022 | 62.35 | 45.55 | 55.56 |
| Month | High Price | Low Price | Average Price |
|---|---|---|---|
| Jun-2022 | 48.10 | 38.60 | 44.15 |
| May-2022 | 53.50 | 44.50 | 48.23 |
| Apr-2022 | 62.40 | 45.50 | 56.03 |
The buyback is being undertaken for the following reasons:
1. The Buyback will help the Company to return surplus cash to its shareholders.
2. The Buyback is generally expected to improve return on equity through the distribution of cash and improve earnings per share by the reduction in the equity base of the Company, thereby leading to a long-term increase in shareholders' value.
7 3.0 Rating:  Vote Here ... |
Sorry, we couldn't find any reviews, please check back later.
Marksans Pharma Ltd
11th Floor,
Veera Desai Extension Road,
Oshiwara, Andheri (W), Mumbai - 400 053
Phone: +91 224001 2000
Email: info@marksanspharma.com
Website: http://marksanspharma.com/index.html
Bigshare Services Pvt Ltd
1st Floor, Bharat Tin Works Building,
Opp. Vasant Oasis,Makwana Road,
Marol, Andheri(E), Mumbai - 400 059
Phone: +91-22-6263 8200
Email: investor@bigshareonline.com
Website: https://ipo.bigshareonline.com/ipo_status.html
Lead Manager(s)
Registered Broker
The Marksans Pharma Buyback opens on July 15, 2022, and closes on January 14, 2023.
The Marksans Pharma Buyback is a Open Market Through Stock Exchange.
Marksans Pharma Buyback Schedule
| Buyback Opening Date | July 15, 2022 |
| Buyback Closing Date | January 14, 2023 |
| Last date for acceptance of shares | Upon relevant pay-out by the Stock exchange |
The Marksans Pharma Buyback is being offered at Rs ₹60 per share per equity share.
There is no ratio applicable in case of open market offer through stock exchange mechanism.
There is no concept of record date in case of open market through stock exchange mechanism.
The Marksans Pharma Buyback has announced a buyback for an aggregate amount of not more than Rs. ₹60.00 Crores with pricing of Rs.₹60 per share.
The buyback is being undertaken for the following reasons:
1. The Buyback will help the Company to return surplus cash to its shareholders.
2. The Buyback is generally expected to improve return on equity through the distribution of cash and improve earnings per share by the reduction in the equity base of the Company, thereby leading to a long-term increase in shareholders' value.
Any equity shareholder holding the shares in Demat form can participate in the buyback offer through their stockbroker. The physical shareholder can participate only once the shares get converted into a Dematerialized form.
The shareholder needs to inform their broker on the details of the Equity shares they wish to sell. The broker will place a sell order whenever the company places a buy order for the buyback. The trade would get executed at the offer price or lesser only when the price offered by the shareholder matches with the buy order placed by the company.
The Marksans Pharma Buyback offers an opportunity for the shareholders to exit their positions at a premium price. In case you stay invested you would have an increased percentage of shareholding in the company and improved earnings per share. Thus, one should understand the company fundamentals along with one's need, goals, and risk appetite to decide if one wants to stay invested or participate in the buyback offer.
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
